It is our great pleasure to announce that “2nd International Symposium on Sustainable Drug Design and Innovative Nanoparticulate Development: Protein and Technology Transfer” organized by Nirmala College of Pharmacy (An Autonomous institution, Affiliated to Acharya Nagarjuna University, Guntur), Mangalagiri, Andhra Pradesh, India will be held on February 20 and 21, 2026.

The proposed International Symposium aims to provide a dynamic platform for leading scientists, students, young pioneering researcher from academic, industry, regulatory experts, and corporate sector from different parts of the globe to deliberate on emerging concepts that integrate drug and dosage development, green chemistry, protein and peptide-based therapeutics, AI-driven drug design, technology transfer and sustainable nanotechnology.

In the evolving landscape of pharmaceutical sciences, there is a critical need to design therapeutics that is efficient, safe, and environmentally responsible. This symposium seeks to foster innovation by bridging multidisciplinary domains, computational biology, bioinformatics, materials science, toxicology, and regulatory science towards a unified goal of sustainable and intelligent drug development. The symposium will feature plenary lectures, oral talks and posters broadly covering the following fields.

Objective:

Sustainable Approaches in Drug Design

Encourage eco-friendly and green chemistry methodologies in drug synthesis, formulation, and manufacturing.

Discuss strategies to reduce environmental impact and enhance sustainability across the drug development lifecycle.

Explore the Role of Proteins and Peptides in Modern Drug Design

Examine advances in protein–ligand interactions, structural biology, and peptide-based therapeutics.

Foster discussions on computational and experimental methods for protein-targeted drug discovery.

Integrate Artificial Intelligence (AI), Machine learning in Drug and Dosage Design

Demonstrate applications of AI and machine learning in rational drug design, QSAR modeling, and formulation optimization.

Highlight successful case studies where AI has accelerated the transition from discovery to preclinical stages.

Advance Nanoparticulate and Nano-biotechnological Innovations

Discuss the design, synthesis, and characterization of eco-friendly nanoparticles for targeted and controlled drug delivery.

Explore biodegradable and biocompatible nanomaterials that align with sustainable pharmaceutical practices.

Evaluate Toxicological and Safety Profiles of Emerging Drug Systems

Examine in-vitro, in-vivo, and computational toxicological approaches for assessing novel drug entities and nanoparticles.

Develop consensus on safe and ethical testing frameworks for next-generation therapeutics.

Addressing Technology transfer, Regulatory and Translational Challenges

Review evolving global regulatory frameworks for nanomedicines, biologics, and peptide drugs.

Facilitate understanding of quality assurance, GMP compliance, and safety assessment in line with international standards.

Strengthen Academia–Industry–Regulatory Collaboration

Promote knowledge sharing and technology transfer between academic institutions, R&D laboratories, and pharmaceutical industries.

Identify opportunities for public–private partnerships to translate laboratory research into viable therapeutic products.

Build Global Networks for Future Research and Innovation

Provide a platform for researchers, scientists, regulators, and industry experts to establish interdisciplinary and international collaborations.

Encourage joint projects, exchange programs, and co-authored research initiatives focusing on sustainable pharmaceutical technologies.